Anebulo Pharmaceuticals, Inc. (ANEB): Price and Financial Metrics
ANEB Price/Volume Stats
| Current price | $0.99 | 52-week high | $3.30 |
| Prev. close | $1.11 | 52-week low | $0.80 |
| Day low | $0.80 | Volume | 88,100 |
| Day high | $1.27 | Avg. volume | 7,740 |
| 50-day MA | $1.61 | Dividend yield | N/A |
| 200-day MA | $2.18 | Market Cap | 25.67M |
ANEB Stock Price Chart Interactive Chart >
Anebulo Pharmaceuticals, Inc. (ANEB) Company Bio
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients suffering from cannabinoid overdose and addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
ANEB Price Returns
| 1-mo | -34.00% |
| 3-mo | -67.86% |
| 6-mo | -62.50% |
| 1-year | -61.92% |
| 3-year | -84.77% |
| 5-year | N/A |
| YTD | -59.09% |
| 2023 | -0.15% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...